Translating extraordinary science into life-changing therapeutics for patients living with cancer

Accent is taking a novel view of cancer – leveraging our industry-leading expertise in RNA-modifying protein (RMPs) biology. We look beyond mutation-specific vulnerabilities to identify and exploit critical intracellular dependencies that span multiple types of cancer and develop small molecule therapeutics designed to inhibit those targets and offer far-reaching potential for patients. Our approach has identified numerous high-value programs, both first-in-class and best-in-class, for which we strive to benefit large patient populations with significant unmet medical need.